Skip to main content

Advertisement

SpringerLink
Log in

Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

Increasing evidence links Alzheimer’s disease (AD) with misbalanced Cu homeostasis. Recently, we have shown that dietary Cu supplementation in a transgenic mouse model for AD increases bioavailable brain Cu levels, restores Cu, Zn-super oxide-1 activity, prevents premature death, and lowers Aβ levels. In the present report we investigated AD patients with normal levels of Aβ42, Tau and Phospho-Tau in the cerebrospinal fluid (CSF) in comparison with AD patients exhibiting aberrant levels in these CSF biomarkers. The influence of these cerebrospinal fluid (CSF) diagnostic markers with primary dependent variables blood Cu, Zn and ceruloplasmin (CB) and secondary with CSF profiles of Cu, Zn and neurotransmitters was determined. Multivariate tests revealed a significant effect of factor diagnostic group (no AD diagnosis in CSF or AD diagnosis in CSF) for variables plasma Cu and CB (F = 4.80; df = 2, 23; p = 0.018). Subsequent univariate tests revealed significantly reduced plasma Cu (−12.7%; F = 7.05; df = 1, 25; p = 0.014) and CB (−14.1%; F = 9.44; df = 1, 24; p = 0.005) levels in patients with aberrant CSF biomarker concentrations. Although only AD patients were included, the reduced plasma Cu and CB levels in patients with a CSF diagnosis of advanced AD supports previous observations that a mild Cu deficiency might contribute to AD progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • N Andreasen M Sjogren K Blennow (2003) ArticleTitleCSF markers for Alzheimer’s disease: total tau, phospho-tau and Abeta42 World J Biol Psychiatry 4 147–155 Occurrence Handle14608585 Occurrence Handle10.1080/15622970310029912

    Article  PubMed  Google Scholar 

  • B Angeletti KJ Waldron KB Freeman H Bawagan I Hussain CC Miller KF Lau ME Tennant C Dennison NJ Robinson C Dingwall (2005) ArticleTitleBACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper J Biol Chem 280 17930–17937 Occurrence Handle15722349 Occurrence Handle1:CAS:528:DC%2BD2MXjsl2hsrY%3D Occurrence Handle10.1074/jbc.M412034200

    Article  PubMed  CAS  Google Scholar 

  • CS Atwood RC Scarpa X Huang RD Moir WD Jones DP Fairlie RE Tanzi AI Bush (2000) ArticleTitleCharacterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42 J Neurochem 75 1219–1233 Occurrence Handle10936205 Occurrence Handle1:CAS:528:DC%2BD3cXmtFyrsLs%3D Occurrence Handle10.1046/j.1471-4159.2000.0751219.x

    Article  PubMed  CAS  Google Scholar 

  • KJ Barnham WJ McKinstry G Multhaup D Galatis CJ Morton CC Curtain NA Williamson AR White MG Hinds RS Norton K Beyreuther CL Masters MW Parker R Cappai (2003) ArticleTitleStructure of the Alzheimer’s disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis J Biol Chem 278 17401–17407 Occurrence Handle12611883 Occurrence Handle1:CAS:528:DC%2BD3sXjsVKmsbo%3D Occurrence Handle10.1074/jbc.M300629200

    Article  PubMed  CAS  Google Scholar 

  • TB Bartnikas JD Gitlin (2003) ArticleTitleMechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase J Biol Chem 278 33602–33608 Occurrence Handle12815046 Occurrence Handle1:CAS:528:DC%2BD3sXms1altbw%3D Occurrence Handle10.1074/jbc.M305435200

    Article  PubMed  CAS  Google Scholar 

  • TA Bayer R Cappai CL Masters K Beyreuther G Multhaup (1999) ArticleTitleIt all sticks together-the APP-related family of proteins and Alzheimer’s disease Mol Psychiatry 4 524–528 Occurrence Handle10578233 Occurrence Handle1:CAS:528:DC%2BD3cXlvVeqsbk%3D Occurrence Handle10.1038/sj.mp.4000552

    Article  PubMed  CAS  Google Scholar 

  • TA Bayer S Schäfer A Simons A Kemmling T Kamer R Tepest A Eckert K Schüssel O Eikenberg C Sturchler-Pierrat D Abramowski M Staufenbiel G Multhaup (2003) ArticleTitleDietary Cu stabilizes brain SOD-1 activity and reduces amyoid Aβ production in APP23 transgenic mice PNAS 100 14187–14192 Occurrence Handle14617773 Occurrence Handle1:CAS:528:DC%2BD3sXpsFGitbg%3D Occurrence Handle10.1073/pnas.2332818100

    Article  PubMed  CAS  Google Scholar 

  • MF Beal JH Growdon (1986) ArticleTitleCSF neurotransmitter markers in Alzheimer’s disease Prog Neuropsychopharmacol Biol Psychiatry 10 259–270 Occurrence Handle2879317 Occurrence Handle1:CAS:528:DyaL2sXmsFSntQ%3D%3D Occurrence Handle10.1016/0278-5846(86)90006-0

    Article  PubMed  CAS  Google Scholar 

  • T Borchardt J Camakaris R Cappai CL Masters K Beyreuther G Multhaup (1999) ArticleTitleCopper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion Biochem J 344 461–467 Occurrence Handle10567229 Occurrence Handle1:CAS:528:DC%2BD3cXltFKq Occurrence Handle10.1042/0264-6021:3440461

    Article  PubMed  CAS  Google Scholar 

  • AI Bush (2003) ArticleTitleThe metallobiology of Alzheimer’s disease Trends Neurosci 26 207–214 Occurrence Handle12689772 Occurrence Handle1:CAS:528:DC%2BD3sXis12nsb8%3D Occurrence Handle10.1016/S0166-2236(03)00067-5

    Article  PubMed  CAS  Google Scholar 

  • RA Cherny CS Atwood ME Xilinas DN Gray WD Jones CA McLean KJ Barnham I Volitakis FW Fraser Y Kim X Huang LE Goldstein RD Moir JT Lim K Beyreuther H Zheng RE Tanzi CL Masters AI Bush (2001) ArticleTitleTreatment with a copper–zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer’s disease Transgenic Mice Neuron 30 665–676 Occurrence Handle11430801 Occurrence Handle1:CAS:528:DC%2BD3MXkvFSksbw%3D Occurrence Handle10.1016/S0896-6273(01)00317-8

    Article  PubMed  CAS  Google Scholar 

  • JR Connor P Tucker M Johnson B Snyder (1993) ArticleTitleCeruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer’s disease Neurosci Lett 159 88–90 Occurrence Handle8264985 Occurrence Handle1:CAS:528:DyaK2cXltFKlug%3D%3D Occurrence Handle10.1016/0304-3940(93)90805-U

    Article  PubMed  CAS  Google Scholar 

  • MA Deibel WD Ehmann WR Markesbery (1996) ArticleTitleCopper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress J Neurol Sci 143 137–142 Occurrence Handle8981312 Occurrence Handle1:CAS:528:DyaK2sXisFOrtA%3D%3D Occurrence Handle10.1016/S0022-510X(96)00203-1

    Article  PubMed  CAS  Google Scholar 

  • C Gonzalez T Martin J Cacho MT Brenas T Arroyo B Garcia-Berrocal JA Navajo JM Gonzalez-Buitrago (1999) ArticleTitleSerum zinc, copper, insulin and lipids in Alzheimer’s disease epsilon 4 apolipoprotein E allele carriers Eur J Clin Invest 29 637–642 Occurrence Handle10411671 Occurrence Handle1:STN:280:DyaK1MzktVChtw%3D%3D Occurrence Handle10.1046/j.1365-2362.1999.00471.x

    Article  PubMed  CAS  Google Scholar 

  • CG Gottfries SO Frederiksen M Heilig (1995) ArticleTitleNeuropeptides and Alzheimer’s disease Eur Neuropsychopharmacol 5 491–500 Occurrence Handle8998402 Occurrence Handle1:CAS:528:DyaK2MXhtVSgsbjJ Occurrence Handle10.1016/0924-977X(95)00038-Q

    Article  PubMed  CAS  Google Scholar 

  • H Hampel SJ Teipel T Fuchsberger N Andreasen J Wiltfang M Otto Y Shen R Dodel Y Du M Farlow HJ Moller K Blennow K Buerger (2004) ArticleTitleValue of CSF beta-amyloid1-42 and tau as predictors of Alzheimer’s disease in patients with mild cognitive impairment Mol Psychiatry 9 705–710 Occurrence Handle14699432 Occurrence Handle1:CAS:528:DC%2BD2cXltFWntL4%3D

    PubMed  CAS  Google Scholar 

  • L Hesse D Beher CL Masters G Multhaup (1994) ArticleTitleThe beta A4 amyloid precursor protein binding to copper Febs Lett 349 109–116 Occurrence Handle7913895 Occurrence Handle1:CAS:528:DyaK2cXlvFyrsrw%3D Occurrence Handle10.1016/0014-5793(94)00658-X

    Article  PubMed  CAS  Google Scholar 

  • F Hulstaert K Blennow A Ivanoiu HC Schoonderwaldt M Riemenschneider PP De Deyn C Bancher P Cras J Wiltfang PD Mehta K Iqbal H Pottel E Vanmechelen H Vanderstichele (1999) ArticleTitleImproved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF Neurology 52 1555–1562 Occurrence Handle10331678 Occurrence Handle1:STN:280:DyaK1M3mtVGhsw%3D%3D

    PubMed  CAS  Google Scholar 

  • C Jeandel MB Nicolas F Dubois F Nabet-Belleville F Penin G Cuny (1989) ArticleTitleLipid peroxidation and free radical scavengers in Alzheimer’s disease Gerontology 35 275–282 Occurrence Handle2630382 Occurrence Handle1:STN:280:DyaK3c3gtFOisQ%3D%3D Occurrence Handle10.1159/000213037

    Article  PubMed  CAS  Google Scholar 

  • P Lewczuk H Esselmann M Otto JM Maler AW Henkel MK Henkel O Eikenberg C Antz WR Krause U Reulbach J Kornhuber J Wiltfang (2004) ArticleTitleNeurochemical diagnosis of Alzheimer’s dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau Neurobiol Aging 25 273–281 Occurrence Handle15123331 Occurrence Handle1:CAS:528:DC%2BD2cXhtV2ksLY%3D Occurrence Handle10.1016/S0197-4580(03)00086-1

    Article  PubMed  CAS  Google Scholar 

  • DA Loeffler PA LeWitt PL Juneau AA Sima HU Nguyen AJ DeMaggio CM Brickman GJ Brewer RD Dick MD Troyer L Kanaley (1996) ArticleTitleIncreased regional brain concentrations of ceruloplasmin in neurodegenerative disorders Brain Res 738 265–274 Occurrence Handle8955522 Occurrence Handle1:CAS:528:DyaK28Xms1ejsr4%3D Occurrence Handle10.1016/S0006-8993(96)00782-2

    Article  PubMed  CAS  Google Scholar 

  • MA Lovell JD Robertson WJ Teesdale JL Campbell WR Markesbery (1998) ArticleTitleCopper, iron and zinc in Alzheimer’s disease senile plaques J Neurol Sci 158 47–52 Occurrence Handle9667777 Occurrence Handle1:CAS:528:DyaK1cXjsVentbo%3D Occurrence Handle10.1016/S0022-510X(98)00092-6

    Article  PubMed  CAS  Google Scholar 

  • A Maddalena A Papassotiropoulos B Muller-Tillmanns HH Jung T Hegi RM Nitsch C Hock (2003) ArticleTitleBiochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide 42 Arch Neurol 60 1202–1206 Occurrence Handle12975284 Occurrence Handle10.1001/archneur.60.9.1202

    Article  PubMed  Google Scholar 

  • CJ Maynard R Cappai I Volitakis RA Cherny AR White K Beyreuther CL Masters AI Bush QX Li (2002) ArticleTitleOverexpression of Alzheimer’s disease amyloid-beta opposes the age-dependent elevations of brain copper and iron J Biol Chem 277 44670–44676 Occurrence Handle12215434 Occurrence Handle1:CAS:528:DC%2BD38Xosl2ntLg%3D Occurrence Handle10.1074/jbc.M204379200

    Article  PubMed  CAS  Google Scholar 

  • G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan (1984) ArticleTitleClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease Neurology 34 939–944 Occurrence Handle6610841 Occurrence Handle1:STN:280:DyaL2c3ks1altQ%3D%3D

    PubMed  CAS  Google Scholar 

  • DM McLoughlin CL Standen KF Lau S Ackerley TP Bartnikas JD Gitlin CC Miller (2001) ArticleTitleThe neuronal adaptor protein X11alpha interacts with the copper chaperone for SOD1 and regulates SOD1 activity J Biol Chem 276 9303–9307 Occurrence Handle11115513 Occurrence Handle1:CAS:528:DC%2BD3MXisVCms70%3D Occurrence Handle10.1074/jbc.M010023200

    Article  PubMed  CAS  Google Scholar 

  • MA Mena EG Aguado JG de Yebenes (1984) ArticleTitleMonoamine metabolites in human cerebrospinal fluid. HPLC/ED method Acta Neurol Scand 69 218–225 Occurrence Handle6204498 Occurrence Handle1:CAS:528:DyaL2cXkvVCjtb8%3D Occurrence Handle10.1111/j.1600-0404.1984.tb07804.x

    Article  PubMed  CAS  Google Scholar 

  • G Multhaup A Schlicksupp L Hesse D Beher T Ruppert CL Masters K Beyreuther (1996) ArticleTitleThe amyloid precursor protein of Alzheimer’s disease in the reduction of copper(II) to copper(I) Science 271 1406–1409 Occurrence Handle8596911 Occurrence Handle1:CAS:528:DyaK28XhsFegtbw%3D

    PubMed  CAS  Google Scholar 

  • F Pajonk H Kessler T Supprian P Hamzei D Bach J Schweickhardt W Herrmann R Obeid A Simons P Falkai G Multhaup T Bayer (2005) ArticleTitleCognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer’s disease J Alzheimers Dis 8 23–27 Occurrence Handle16155346 Occurrence Handle1:CAS:528:DC%2BD2MXpvVKjtbo%3D

    PubMed  CAS  Google Scholar 

  • AL Phinney B Drisaldi S Lugowski S Schmidt H Bonek Y Liang P Home L Yang J Sekoulidis J Coomaraswarmy D Cox PM Mathews RA Nixon GA Carlson P St George-Hyslop D Westaway (2003) ArticleTitleIn vivo reduction of amyloid Aβ by a mutant copper transporter PNAS 100 14193–14198 Occurrence Handle14617772 Occurrence Handle1:CAS:528:DC%2BD3sXpsFGitbk%3D Occurrence Handle10.1073/pnas.2332851100

    Article  PubMed  CAS  Google Scholar 

  • V Rizzo A Anesi L Montalbetti G Bellantoni R Trotti GV Melzi d’Eril (1996) ArticleTitleReference values of neuroactive amino acids in the cerebrospinal fluid by high-performance liquid chromatography with electrochemical and fluorescence detection J Chromatogr A 729 181–188 Occurrence Handle9004939 Occurrence Handle1:CAS:528:DyaK28XjtFeht7s%3D Occurrence Handle10.1016/0021-9673(95)01170-6

    Article  PubMed  CAS  Google Scholar 

  • NS Schoonenboom YA Pijnenburg C Mulder SM Rosso EJ Van Elk GJ Van Kamp JC Van Swieten P Scheltens (2004) ArticleTitleAmyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease Neurology 62 1580–1584 Occurrence Handle15136685 Occurrence Handle1:CAS:528:DC%2BD2cXjt1ylurw%3D

    PubMed  CAS  Google Scholar 

  • J Snaedal J Kristinsson S Gunnarsdottir E Olafsdottir M Baldvinsson T Johannesson (1998) ArticleTitleCopper, ceruloplasmin and superoxide dismutase in patients with Alzheimer’s disease. A case-control study Dement Geriatr Cogn Disord 9 239–242 Occurrence Handle9701674 Occurrence Handle1:CAS:528:DyaK1cXmtVOrtro%3D Occurrence Handle10.1159/000017067

    Article  PubMed  CAS  Google Scholar 

  • R Squitti D Lupoi P Pasqualetti G Dal Forno F Vernieri P Chiovenda L Rossi M Cortesi E Cassetta PM Rossini (2002) ArticleTitleElevation of serum copper levels in Alzheimer’s disease Neurology 59 1153–1161 Occurrence Handle12391342 Occurrence Handle1:CAS:528:DC%2BD38Xns1Snsro%3D

    PubMed  CAS  Google Scholar 

  • G Torsdottir J Kristinsson S Hreidarsson J Snaedal T Johannesson (2001) ArticleTitleCopper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down’s syndrome Pharmacol Toxicol 89 320–325 Occurrence Handle11903959 Occurrence Handle1:CAS:528:DC%2BD38XovFGj Occurrence Handle10.1034/j.1600-0773.2001.d01-168.x

    Article  PubMed  CAS  Google Scholar 

  • C Treiber A Simons M Strauss M Hafner R Cappai TA Bayer G Multhaup (2004) ArticleTitleClioquinol Mediates Copper Uptake and Counteracts Copper Efflux Activities of the Amyloid Precursor Protein of Alzheimer’s Disease J Biol Chem 279 51958–51964 Occurrence Handle15465814 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCktbjK Occurrence Handle10.1074/jbc.M407410200

    Article  PubMed  CAS  Google Scholar 

  • JR Turnlund RA Jacob CL Keen JJ Strain DS Kelley JM Domek WR Keyes JL Ensunsa J Lykkesfeldt J Coulter (2004) ArticleTitleLong-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men Am J Clin Nutr 79 1037–1044 Occurrence Handle15159234 Occurrence Handle1:CAS:528:DC%2BD2cXksVyqur8%3D

    PubMed  CAS  Google Scholar 

  • AR White R Reyes JF Mercer J Camakaris H Zheng AI Bush G Multhaup K Beyreuther CL Masters R Cappai (1999) ArticleTitleCopper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice Brain Res 842 439–444 Occurrence Handle10526140 Occurrence Handle1:CAS:528:DyaK1MXmsVWns7w%3D Occurrence Handle10.1016/S0006-8993(99)01861-2

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany

    H. Kessler, F.-G. Pajonk, P. Meisser, T. Schneider-Axmann, K.-H. Hoffmann, T. Supprian, P. Falkai & T. A. Bayer

  2. Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany

    W. Herrmann & R. Obeid

  3. Institute for Chemistry-Biochemistry, Free University of Berlin, Berlin, Germany

    G. Multhaup

Authors
  1. H. Kessler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F.-G. Pajonk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Meisser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Schneider-Axmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K.-H. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Supprian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W. Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Obeid
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Multhaup
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P. Falkai
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. T. A. Bayer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The first and second author contributed equally

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kessler, H., Pajonk, FG., Meisser, P. et al. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease. J Neural Transm 113, 1763–1769 (2006). https://doi.org/10.1007/s00702-006-0485-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-006-0485-7

Search

Navigation